Trial Profile

Phase I, Double Blind, Randomized, Placebo-controlled, Dose Escalation Study to Assess the Safety and Immunogenicity of a Prophylactic Vaccine Against Enterovirus Infection in Healthy Adults

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 01 Jul 2019

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Enterovirus A vaccine (Primary)
Indications Enterovirus A infections
Focus Adverse reactions
Sponsors Inviragen

Most Recent Events

20 Jun 2019 Results (n=36) were published in the Vaccine.
11 Mar 2012 Complete safety and immunogenicity results will be reported at an infectious disease meeting in 2012, according to an Inviragen media release.
11 Mar 2012 Status changed from active, no longer recruiting to completed, according to an Inviragen media release.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com